Literature DB >> 7521904

Microglia in diffuse plaques in hereditary cerebral hemorrhage with amyloidosis (Dutch). An immunohistochemical study.

M L Maat-Schieman1, A J Rozemuller, S G van Duinen, J Haan, P Eikelenboom, R A Roos.   

Abstract

In hereditary cerebral hemorrhage with amyloidosis (Dutch) (HCHWA-D) beta/A4 amyloid deposition is found in meningocortical blood vessels and in diffuse plaques in the cerebral cortex. Diffuse plaques putatively represent early stages in the formation of senile plaques. Microglia are intimately associated with congophilic plaques in Alzheimer's disease (AD), but microglial involvement in diffuse plaque formation is controversial. Therefore, we studied the relationship between microglia and diffuse plaques in the cerebral cortex of four patients with HCHWA-D using a panel of macrophage/microglia markers (mAbs LCA, LeuM5, LeuM3, LN3, KP1, OKIa, CLB54, Mac1, Ki-M6, AMC30 and the lectin RCA-1). Eight AD patients, one demented Down's syndrome (DS) patient and four non-demented controls were included for comparison. In controls and HCHWA-D patients ramified or "resting" microglia formed a reticular array in cortical gray and subcortical white matter. Microglial cells in or near HCHWA-D diffuse plaques retained their normal regular spacing and ramified morphology. In AD/DS gray matter more microglial cells were stained than in controls and HCHWA-D patients. Intensely immunoreactive microglia with enlarged cell bodies and short, thick processes clustered in congophilic plaques. In contrast to the resting microglia, these "activated microglia" strongly expressed class II major histocompatibility complex antigen, HLA-DR, and were AMC30-immunoreactive. These findings support the view that microglia play a role in the formation of congophilic plaques but do not initiate diffuse plaque formation. Another finding in this study is the presence of strong monocyte/macrophage marker immunoreactivity in the wall of cortical congophilic blood vessels in HCHWA-D.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521904     DOI: 10.1097/00005072-199409000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  The Orphan C2orf40 Gene is a Neuroimmune Factor in Alzheimer's Disease.

Authors:  Sonia Podvin; Miles C Miller; Ryan Rossi; Jasmine Chukwueke; John E Donahue; Conrad E Johanson; Andrew Baird; Edward G Stopa
Journal:  JSM Alzheimers Dis Relat Dement       Date:  2016-04-01

2.  A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques.

Authors:  M M Verbeek; I Otte-Höller; P Wesseling; W E Van Nostrand; C Sorg; D J Ruiter; R M de Waal
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques.

Authors:  D M Mann; T Iwatsubo; H Fukumoto; Y Ihara; A Odaka; N Suzuki
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Microglial responses to dopamine in a cell culture model of Parkinson's disease.

Authors:  Diego Mastroeni; Andrew Grover; Brian Leonard; Jeffrey N Joyce; Paul D Coleman; Brooke Kozik; Denise L Bellinger; Joseph Rogers
Journal:  Neurobiol Aging       Date:  2008-03-05       Impact factor: 4.673

5.  The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.

Authors:  Jie Zhao; Tracy O'Connor; Robert Vassar
Journal:  J Neuroinflammation       Date:  2011-11-02       Impact factor: 8.322

6.  Microglia in Alzheimer brain: a neuropathological perspective.

Authors:  Robert E Mrak
Journal:  Int J Alzheimers Dis       Date:  2012-05-13

Review 7.  Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells.

Authors:  Rafael Franco; Alejandro Lillo; Rafael Rivas-Santisteban; Irene Reyes-Resina; Gemma Navarro
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.